| HOME >> MEDICINE >> TECHNOLOGY |
Table 3: CNS Disorder Therapeutic Market, Global, Annual Cost of Treatment ($), 2002-2010 18
Table 4: CNS Disorder Therapeutic Market, Global, Annual Cost of Treatment ($), 2010-2017 18
Table 5: CNS Disorder Therapeutic Market, The US, Revenue ($m), 2002-2010 25
Table 6: CNS Disorder Therapeutic Market, The US, Revenue Forecast($m), 2010-2017 25
Table 7: CNS Disorder Therapeutic Market, The US, Annual Cost of Treatment ($), 2002-2010 26
Table 8: CNS Disorder Therapeutic Market, The US, Annual Cost of Treatment ($), 2010-2017 26
Table 9: CNS Disorder Therapeutic Market, Top Five Countries of Europe, Revenue ($m), 2002-2010 28
Table 10: CNS Disorder Therapeutic Market, Top Five Countries of Europe, Revenue Forecast ($m), 2010-2017 28
Table 11: CNS Disorder Therapeutic Market, Top Five Countries of Europe, Annual Cost of Treatment ($), 2002-2010 29
Table 12: CNS Disorder Therapeutic Market, Top Five Countries of Europe, Annual Cost of Treatment ($), 2010-2017 29
Table 13: CNS Disorder Therapeutic Market, Japan, Revenue ($m), 2002-2010 30
Table 14: CNS Disorder Therapeutic Market, Japan, Revenue Forecast ($m), 2010-2017 30
Table 15: CNS Disorder Therapeutic Market, Japan, Annual Cost of Treatment ($), 2002-2010 31
Table 16: CNS Disorder Therapeutic Market, Japan, Annual Cost of Treatment ($), 2010-2017 31
Table 17: CNS Disorder Therapeutic Market, Alzheimer's Disease, FDA Approved Cholinesterase Inhibitors, 2010 33
Table 18: CNS Disorder Therapeutic Market, Alzheimer's Disease, Global Revenue ($bn), 2002-2010 34
Table 19: CNS Disorder Therapeutic Market, Alzheimer's Disease, Global Revenue Forecast ($bn), 2010-2017 34
Table 20: CNS Disorder Therapeutics Market, Alzheimer's Disease, Revenue by Country ($m), 2002-2010 36
Table 21: CNS Disorder Therapeutics Market, Alzheimer
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |